These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 12574972

  • 1. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
    Hoffend J, Linke G, Mohammed A, Tiefenbacher CP, Eisenhut M, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biological evaluation of a technetium-99m-labeled integrated tropane-BAT and its piperidine congener as potential dopamine transporter imaging agents.
    Kieffer DM, Vanbilloen HP, Cleynhens BJ, Terwinghe CY, Mortelmans L, Bormans GM, Verbruggen AM.
    Nucl Med Biol; 2006 Jan; 33(1):125-33. PubMed ID: 16459268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 18F-labelled annexin V: a PET tracer for apoptosis imaging.
    Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, Tait JF, Nishimura S.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):469-74. PubMed ID: 14666384
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
    Boschi A, Uccelli L, Bolzati C, Duatti A, Sabba N, Moretti E, Di Domenico G, Zavattini G, Refosco F, Giganti M.
    J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and evaluation of [99mTcN]2+ core and [99mTcO]3+ core labeled complexes with 4-nitroimidazole xanthate derivative for tumor hypoxia imaging.
    Ruan Q, Zhang X, Gan Q, Fang S, Zhang J.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127582. PubMed ID: 33002601
    [Abstract] [Full Text] [Related]

  • 8. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
    Li Z, Lin X, Zhang J, Wang X, Jin Z, Zhang W, Zhang Y.
    Nucl Med Biol; 2016 Feb 15; 43(2):165-70. PubMed ID: 26872441
    [Abstract] [Full Text] [Related]

  • 9. Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F-FRP170.
    Kaneta T, Takai Y, Kagaya Y, Yamane Y, Wada H, Yuki M, Iwata R, Tsujitani M, Takahashi S, Yamada S.
    J Nucl Med; 2002 Jan 15; 43(1):109-16. PubMed ID: 11801713
    [Abstract] [Full Text] [Related]

  • 10. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
    Ng CK, Sinusas AJ, Zaret BL, Soufer R.
    Circulation; 1995 Sep 01; 92(5):1261-8. PubMed ID: 7648674
    [Abstract] [Full Text] [Related]

  • 11. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
    Okada DR, Johnson G, Liu Z, Hocherman SD, Khaw BA, Pak KY, Okada RD.
    J Nucl Cardiol; 2003 Sep 01; 10(2):168-76. PubMed ID: 12673182
    [Abstract] [Full Text] [Related]

  • 12. Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium.
    Riou LM, Ghezzi C, Vanzetto G, Broisat A, Mathieu JP, Bontron R, Pasqualini R, Fagret D.
    J Nucl Med; 2003 Jun 01; 44(6):981-7. PubMed ID: 12791829
    [Abstract] [Full Text] [Related]

  • 13. Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.
    Chu T, Li R, Hu S, Liu X, Wang X.
    Nucl Med Biol; 2004 Feb 01; 31(2):199-203. PubMed ID: 15013485
    [Abstract] [Full Text] [Related]

  • 14. Serial changes in BMIPP uptake in relation to thallium uptake in the rat myocardium after ischaemia.
    Noriyasu K, Mabuchi M, Kuge Y, Morita K, Tsukamoto T, Kohya T, Kitabatake A, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2003 Dec 01; 30(12):1644-50. PubMed ID: 12955484
    [Abstract] [Full Text] [Related]

  • 15. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
    Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T.
    J Nucl Med; 1994 Aug 01; 35(8):1371-6. PubMed ID: 8046496
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biodistribution of a new (99m) Tc-oxo complex with deoxyglucose dithiocarbamate for tumor imaging.
    Lin X, Jin Z, Ren J, Pang Y, Zhang W, Huo J, Wang X, Zhang J, Zhang Y.
    Chem Biol Drug Des; 2012 Mar 01; 79(3):239-45. PubMed ID: 22136603
    [Abstract] [Full Text] [Related]

  • 17. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction.
    Kalinowski L, Dobrucki LW, Meoli DF, Dione DP, Sadeghi MM, Madri JA, Sinusas AJ.
    J Appl Physiol (1985); 2008 May 01; 104(5):1504-12. PubMed ID: 18356482
    [Abstract] [Full Text] [Related]

  • 18. Mapping of the cardiac sympathetic nervous system by single photon emission tomography with technetium-99m-labelled fluorobenzylpiperidine derivative (99mTc-FBPBAT): result of a feasibility study in a porcine model and an initial dosimetric estimation in humans.
    Richter S, Schaefer A, Menger MD, Kirsch CM, Samnick S.
    Nucl Med Commun; 2005 Apr 01; 26(4):361-8. PubMed ID: 15753796
    [Abstract] [Full Text] [Related]

  • 19. Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.
    Kim YS, Wang J, Broisat A, Glover DK, Liu S.
    J Nucl Cardiol; 2008 Apr 01; 15(4):535-46. PubMed ID: 18674722
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK.
    J Nucl Med; 2004 Dec 01; 45(12):2095-101. PubMed ID: 15585487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.